A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time such therapy, which can reset the ...

The field of partial reprogramming is transitioning from successful mouse studies to its first human clinical trials. At the heart of this experiment lies the discovery of Yamanaka ...

For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.

The idea that cells could be reset emerged from decades of research in regenerative medicine. The field traces back to 1962, ...

In 2006, Kyoto University’s Professor Yamanaka Shin’ya made a groundbreaking discovery: a method to reprogram ordinary body cells such as skin, nerve, or bone cells into a highly adaptable, ...

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...